Holen Sie sich die Stockscreener-App
9.40
1.36%
-0.13
Handel nachbörslich:
9.41
0.010
+0.11%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$9.53
Offen:
$9.52
24-Stunden-Volumen:
4.89M
Relative Volume:
0.96
Marktkapitalisierung:
$1.87B
Einnahmen:
$3.68B
Nettoeinkommen (Verlust:
$-627.00M
KGV:
-2.9863
EPS:
-3.1477
Netto-Cashflow:
$104.00M
1W Leistung:
-1.47%
1M Leistung:
-14.31%
6M Leistung:
-19.52%
1J Leistung:
-24.01%
1-Tages-Spanne:
$9.29
$9.625
1-Wochen-Bereich:
$9.29
$10.02
52-Wochen-Spanne:
$9.29
$14.76
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
9.40 | 1.87B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Sell |
| 2026-02-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dentsply Sirona's Troubles Are Nothing To Smile About (Downgrade) (NASDAQ:XRAY) - Seeking Alpha
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks - Yahoo Finance
Dentsply Sirona stock hits 52-week low at 9.35 USD By Investing.com - Investing.com Nigeria
Dentsply Sirona stock hits 52-week low at 9.35 USD - Investing.com
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year LowTime to Sell? - MarketBeat
DS World Las Vegas opens with expanded hands-on education programme - Dental Tribune US
DENTSPLY SIRONA stock falls 1.71 percent after Q2 data - AD HOC NEWS
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
DENTSPLY SIRONA stock weighs Q2 beat against 4.1% sales drop - AD HOC NEWS
Dentsply Sirona stock gains 5.40 percent as earnings beat estimates - AD HOC NEWS
Bank of America Corp DE Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona: The Valuation Is Low, But The Turnaround Is Not Proven Yet (NASDAQ:XRAY) - Seeking Alpha
Squarepoint Ops LLC Sells 431,734 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona stock stays near $9.54 after valuation reset - AD HOC NEWS
DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year LowTime to Sell? - MarketBeat
Dentsply Sirona Inc stock hits 52-week low at 9.4 USD - Investing.com Nigeria
Dentsply Sirona Inc stock hits 52-week low at 9.4 USD By Investing.com - Investing.com South Africa
DENTSPLY SIRONA Q2 2026 Earnings: EPS Beat Overshadowed by Sharp Stock DeclineEPS Surprise History - careplusvn.com
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now - Zacks Investment Research
DENTSPLY SIRONA (NASDAQ:XRAY) Shares Down 3.6%Here's What Happened - MarketBeat
J.P. Morgan Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Announces Target Price $12 - Moomoo
Dentsply Sirona Is Maintained at Market Perform by BMO Capital - Moomoo
BMO Capital Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $10 - Moomoo
DENTSPLY SIRONA Inc. $XRAY Stock Holdings Decreased by Amundi - MarketBeat
DENTSPLY SIRONA Inc. (XRAY) Stock forecasts - uk.finance.yahoo.com
Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Dentsply Securities Litigation - marketscreener.com
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
ETFs Investing in DENTSPLY SIRONA, Inc. Stocks - TradingView
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 182,661 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Investor Suit Over Pandemic Woes Lined Up For Trial - law360.com
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure - Yahoo Finance
Law firm investigates Dentsply Sirona officers for possible breaches of shareholder duties - Pluang
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Legal & General Group Plc Makes New $3.25 Million Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation - Yahoo Finance
Dentsply Sirona (XRAY) Stock May Still Trade At A Discount - Yahoo Finance
The Manufacturers Life Insurance Company Takes Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis? - Yahoo Finance
A live webcast will carry Dentsply Sirona’s Sept. 15 presentation - Stock Titan
Dentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding - Yahoo Finance
DENTSPLY SIRONA (XRAY) Rises to $11.43 — Approaching Key $12.0 Resistance ZoneNHNL Divergence - careplusvn.com
Is It Too Late to Buy Dentsply Sirona Inc (XRAY) After 4.8% Rall - GuruFocus
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Bank of New York Mellon Corp Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc (DY2) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Private Management Group Inc. - MarketBeat
Algert Global LLC Acquires New Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) Edges Higher: Dental Giant Tests Key Resistance Near $11.68Institutional Buy Signals - careplusvn.com
Zacks Research Forecasts Weaker Earnings for DENTSPLY SIRONA - MarketBeat
Dentsply Sirona Inc (XRAY) Key Financial Ratios – Valuation, Profitability & More - Value Research
Deutsche Bank AG Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - marketbeat.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):